{
  "retracted": false,
  "timestamp": 1472688000000,
  "updates": [
    {
      "timestamp": 1495736615233,
      "identifier": {
        "doi": "10.1016/j.kint.2016.06.006"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.kint.2015.11.026"
  },
  "publisher": "Elsevier BV",
  "title": "Greenbaum LA, Fila M, Ardissino G, et al. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. Kidney Int. 2016;89:701–711"
}
